Anthropic fell as low as $83.05 on its second day of trading, 5 cents above its $83 IPO price, then closed at $88.30. Facebook closed its second day 10% below its IPO price.
One stock just debuted at a $1.5 trillion valuation and promptly sank, while the original crypto rebel sits near its yearly low. Before the December Fed decision, one of them offers a far clearer…
A retiree ready to buy a house with her 401(k) faces a tax bill that hinges on one calendar quirk and a builder willing to bargain. Two hidden costs could still trip her up…
Three monthly dividend payers share one external adviser, which gives you a single playbook and a single point of failure. One of them already cut its payout once, and another just leaned on a…
An insurer will turn a lump sum into a paycheck that outlasts any bank account, but the contract quietly keeps the leftovers if you die early. Before you sign, learn the taxes, the inflation…
A coin that once soared past $73 now trades under a dollar, and a dinner with the president is not saving it. Token unlocks keep landing until 2028, so can anything push those holders…
Humana has surged this year, yet investors who bought at the wrong moment are still underwater. Medicare Advantage growth, Star Ratings, and a looming December investor update will decide whether the rebound lasts.
Your doctor's bill can earn you rewards, and your HSA can quietly repay you years later without a tax bill. One missed receipt, one surcharge, or one unpaid balance can erase the whole advantage.
Crypto bled while Wall Street cheered a record $81.3 billion listing, and XRP slipped below a dollar. SpaceX's debut offered a playbook, but a Fed hike and a weaker starting point could rewrite how…